These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 35092722)

  • 21. Randomized placebo controlled trial evaluating the safety and efficacy of single low-dose intracoronary insulin-like growth factor following percutaneous coronary intervention in acute myocardial infarction (RESUS-AMI).
    Caplice NM; DeVoe MC; Choi J; Dahly D; Murphy T; Spitzer E; Van Geuns R; Maher MM; Tuite D; Kerins DM; Ali MT; Kalyar I; Fahy EF; Khider W; Kelly P; Kearney PP; Curtin RJ; O'Shea C; Vaughan CJ; Eustace JA; McFadden EP
    Am Heart J; 2018 Jun; 200():110-117. PubMed ID: 29898838
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mineralocorticoid receptor antagonist pre-treatment and early post-treatment to minimize reperfusion injury after ST-elevation myocardial infarction: The MINIMIZE STEMI trial.
    Bulluck H; Fröhlich GM; Nicholas JM; Mohdnazri S; Gamma R; Davies J; Sirker A; Mathur A; Blackman D; Garg P; Moon JC; Greenwood JP; Hausenloy DJ
    Am Heart J; 2019 May; 211():60-67. PubMed ID: 30893577
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Trial design and rationale of TY-51924 as a novel Na+/H+ exchanger inhibitor in patients with ST-elevation acute myocardial infarction undergoing percutaneous coronary intervention.
    Ishihara M; Asakura M; Kimura K; Nakao K; Hamada C; Hirayama A
    J Cardiol; 2014 Jan; 63(1):82-7. PubMed ID: 23860273
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Rationale and design of the RESTORE trial: A multicenter, randomized, double-blinded, parallel-group, placebo-controlled trial to evaluate the effect of Shenfu injection on myocardial injury in STEMI patients after primary PCI.
    Wang X; Guo R; Guo Y; Guo Q; Yan Y; Gong W; Zheng W; Wang H; Xu L; Ai H; Que B; Yan X; Ma X; Nie S
    Am Heart J; 2023 Jun; 260():9-17. PubMed ID: 36822255
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Intra-coronary morphine versus placebo in the treatment of acute ST-segment elevation myocardial infarction: the MIAMI randomized controlled trial.
    Le Corvoisier P; Gallet R; Lesault PF; Audureau E; Paul M; Ternacle J; Ghostine S; Champagne S; Arrouasse R; Bitari D; Mouillet G; Dubois-Randé JL; Berdeaux A; Ghaleh B; Deux JF; Teiger E
    BMC Cardiovasc Disord; 2018 Oct; 18(1):193. PubMed ID: 30340532
    [TBL] [Abstract][Full Text] [Related]  

  • 26. NHLBI-Sponsored Randomized Trial of Postconditioning During Primary Percutaneous Coronary Intervention for ST-Elevation Myocardial Infarction.
    Traverse JH; Swingen CM; Henry TD; Fox J; Wang YL; Chavez IJ; Lips DL; Lesser JR; Pedersen WR; Burke NM; Pai A; Lindberg JL; Garberich RF
    Circ Res; 2019 Mar; 124(5):769-778. PubMed ID: 30602360
    [TBL] [Abstract][Full Text] [Related]  

  • 27. TIME Trial: Effect of Timing of Stem Cell Delivery Following ST-Elevation Myocardial Infarction on the Recovery of Global and Regional Left Ventricular Function: Final 2-Year Analysis.
    Traverse JH; Henry TD; Pepine CJ; Willerson JT; Chugh A; Yang PC; Zhao DXM; Ellis SG; Forder JR; Perin EC; Penn MS; Hatzopoulos AK; Chambers JC; Baran KW; Raveendran G; Gee AP; Taylor DA; Moyé L; Ebert RF; Simari RD
    Circ Res; 2018 Feb; 122(3):479-488. PubMed ID: 29208679
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Early Use of N-acetylcysteine With Nitrate Therapy in Patients Undergoing Primary Percutaneous Coronary Intervention for ST-Segment-Elevation Myocardial Infarction Reduces Myocardial Infarct Size (the NACIAM Trial [N-acetylcysteine in Acute Myocardial Infarction]).
    Pasupathy S; Tavella R; Grover S; Raman B; Procter NEK; Du YT; Mahadavan G; Stafford I; Heresztyn T; Holmes A; Zeitz C; Arstall M; Selvanayagam J; Horowitz JD; Beltrame JF
    Circulation; 2017 Sep; 136(10):894-903. PubMed ID: 28634219
    [TBL] [Abstract][Full Text] [Related]  

  • 29. G-CSF for Extensive STEMI.
    Achilli F; Pontone G; Bassetti B; Squadroni L; Campodonico J; Corrada E; Facchini C; Mircoli L; Esposito G; Scarpa D; Pidello S; Righetti S; Di Gennaro F; Guglielmo M; Muscogiuri G; Baggiano A; Limido A; Lenatti L; Di Tano G; Malafronte C; Soffici F; Ceseri M; Maggiolini S; Colombo GI; Pompilio G;
    Circ Res; 2019 Jul; 125(3):295-306. PubMed ID: 31138020
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of early metoprolol on infarct size in ST-segment-elevation myocardial infarction patients undergoing primary percutaneous coronary intervention: the Effect of Metoprolol in Cardioprotection During an Acute Myocardial Infarction (METOCARD-CNIC) trial.
    Ibanez B; Macaya C; Sánchez-Brunete V; Pizarro G; Fernández-Friera L; Mateos A; Fernández-Ortiz A; García-Ruiz JM; García-Álvarez A; Iñiguez A; Jiménez-Borreguero J; López-Romero P; Fernández-Jiménez R; Goicolea J; Ruiz-Mateos B; Bastante T; Arias M; Iglesias-Vázquez JA; Rodriguez MD; Escalera N; Acebal C; Cabrera JA; Valenciano J; Pérez de Prado A; Fernández-Campos MJ; Casado I; García-Rubira JC; García-Prieto J; Sanz-Rosa D; Cuellas C; Hernández-Antolín R; Albarrán A; Fernández-Vázquez F; de la Torre-Hernández JM; Pocock S; Sanz G; Fuster V
    Circulation; 2013 Oct; 128(14):1495-503. PubMed ID: 24002794
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mineralocorticoid receptor antagonist pretreatment to MINIMISE reperfusion injury after ST-elevation myocardial infarction (the MINIMISE STEMI Trial): rationale and study design.
    Bulluck H; Fröhlich GM; Mohdnazri S; Gamma RA; Davies JR; Clesham GJ; Sayer JW; Aggarwal RK; Tang KH; Kelly PA; Jagathesan R; Kabir A; Robinson NM; Sirker A; Mathur A; Blackman DJ; Ariti C; Krishnamurthy A; White SK; Meier P; Moon JC; Greenwood JP; Hausenloy DJ
    Clin Cardiol; 2015 May; 38(5):259-66. PubMed ID: 25990305
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Complete Revascularization Versus Culprit Lesion Only in Patients With ST-Segment Elevation Myocardial Infarction and Multivessel Disease: A DANAMI-3-PRIMULTI Cardiac Magnetic Resonance Substudy.
    Kyhl K; Ahtarovski KA; Nepper-Christensen L; Ekström K; Ghotbi AA; Schoos M; Göransson C; Bertelsen L; Helqvist S; Holmvang L; Jørgensen E; Pedersen F; Saunamäki K; Clemmensen P; De Backer O; Høfsten DE; Køber L; Kelbæk H; Vejlstrup N; Lønborg J; Engstrøm T
    JACC Cardiovasc Interv; 2019 Apr; 12(8):721-730. PubMed ID: 31000010
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Residual Myocardial Iron Following Intramyocardial Hemorrhage During the Convalescent Phase of Reperfused ST-Segment-Elevation Myocardial Infarction and Adverse Left Ventricular Remodeling.
    Bulluck H; Rosmini S; Abdel-Gadir A; White SK; Bhuva AN; Treibel TA; Fontana M; Ramlall M; Hamarneh A; Sirker A; Herrey AS; Manisty C; Yellon DM; Kellman P; Moon JC; Hausenloy DJ
    Circ Cardiovasc Imaging; 2016 Oct; 9(10):e004940. PubMed ID: 27894068
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of erythropoietin as an adjunct to primary percutaneous coronary intervention: a randomised controlled clinical trial.
    Ludman AJ; Yellon DM; Hasleton J; Ariti C; Babu GG; Boston-Griffiths E; Venugopal V; Walker M; Holdright D; Swanton H; Crake T; Brull D; Moon JC; Puranik R; Muthurangu V; Taylor A; Hausenloy DJ
    Heart; 2011 Oct; 97(19):1560-5. PubMed ID: 21900585
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Outcome of ST-elevation myocardial infarction versus non-ST-elevation acute coronary syndrome treated with titanium-nitride-oxide-coated versus everolimus-eluting stents: insights from the BASE-ACS trial.
    Romppanen H; Nammas W; Kervinen K; Mikkelsson J; Pietilä M; Lalmand J; Rivero-Crespo F; Pentikäinen M; Tedjokusumo P; Karjalainen PP
    Minerva Cardioangiol; 2013 Apr; 61(2):201-9. PubMed ID: 23492603
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Randomized, Placebo-Controlled Phase 2b Study to Evaluate the Safety and Efficacy of Recombinant Human Lecithin Cholesterol Acyltransferase in Acute ST-Segment-Elevation Myocardial Infarction: Results of REAL-TIMI 63B.
    Bonaca MP; Morrow DA; Bergmark BA; Berg DD; Lima JAC; Hoffmann U; Kato Y; Lu MT; Kuder J; Murphy SA; Spinar J; Oude Ophuis T; Kiss RG; Lopez-Sendon J; Averkov O; Wheatcroft SB; Kubica J; Carlos Nicolau J; Furtado RHM; Abuhatzira L; Hirshberg B; Omar SA; Vavere AL; Chang YT; George RT; Sabatine MS
    Circulation; 2022 Sep; 146(12):907-916. PubMed ID: 36039762
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cangrelor versus Ticagrelor in Patients Treated with Primary Percutaneous Coronary Intervention: Impact on Platelet Activity, Myocardial Microvascular Function and Infarct Size: A Randomized Controlled Trial.
    Ubaid S; Ford TJ; Berry C; Murray HM; Wrigley B; Khan N; Thomas MR; Armesilla AL; Townend JN; Khogali SS; Munir S; Martins J; Hothi SS; McAlindon EJ; Cotton JM
    Thromb Haemost; 2019 Jul; 119(7):1171-1181. PubMed ID: 31129911
    [TBL] [Abstract][Full Text] [Related]  

  • 38. UpStreAm doxycycline in ST-eLeVation myocArdial infarction: targetinG infarct hEaling and ModulatIon (SALVAGE-MI trial).
    Noaman S; Neil C; O'Brien J; Frenneaux M; Hare J; Wang B; Yee Tai T; Theuerle J; Shaw J; Stub D; Bloom J; Walton A; Duffy SJ; Peter KH; Cox N; Kaye DM; Taylor A; Chan W
    Eur Heart J Acute Cardiovasc Care; 2023 Apr; 12(3):143-152. PubMed ID: 36567466
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A randomized, double-blind, placebo-controlled study of the safety and efficacy of intravenous MCC-135 as an adjunct to primary percutaneous coronary intervention in patients with acute myocardial infarction: rationale and design of the evaluation of MCC-135 for left ventricular salvage in acute MI (EVOLVE) study.
    Jang IK; Pettigrew V; Picard MH; Kowey PR; Demmel V; Zile MR; Tatsuno J; Wackers FJ; Hibberd M
    J Thromb Thrombolysis; 2005 Dec; 20(3):147-53. PubMed ID: 16261287
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Randomized Trial of Interleukin-6 Receptor Inhibition in Patients With Acute ST-Segment Elevation Myocardial Infarction.
    Broch K; Anstensrud AK; Woxholt S; Sharma K; Tøllefsen IM; Bendz B; Aakhus S; Ueland T; Amundsen BH; Damås JK; Berg ES; Bjørkelund E; Bendz C; Hopp E; Kleveland O; Stensæth KH; Opdahl A; Kløw NE; Seljeflot I; Andersen GØ; Wiseth R; Aukrust P; Gullestad L
    J Am Coll Cardiol; 2021 Apr; 77(15):1845-1855. PubMed ID: 33858620
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.